Todisco Joseph

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$532,342.14
Insider Sells Quantity
2
Insider Sells Sum
$106,057.50

Insider Activity of Todisco Joseph

According to the SEC Form 4 filings, Todisco Joseph, being in a position of

  1. Chief Executive Officer at CorMedix Inc.,
    оver the last 12 months, has bought 13561 share for $50,718, and sold 0 shares,
    over all time since 2022-05-16, has bought 63261 share for $239,342, and sold 0 shares.

The largest purchase of all time was on 2019-05-13 and amounted to 15000 shares of Amneal Pharmaceuticals, Inc. for $148,200.

The largest sale of all time was on 2021-03-15 and amounted to 36330 shares of Amneal Pharmaceuticals, Inc. for $99,908.

Biography of Todisco Joseph

No biography is available at this moment.

2024-03-13PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
13,561
0.024%
$3.74$50,718+32.99%
2023-09-08PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
10,000
0.0183%
$3.71$37,100+1.76%
2023-05-17PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
5,000
0.0119%
$4.58$22,900-13.01%
2022-11-15PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
20,000
0.0514%
$3.82$76,400+11.79%
2022-08-24PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
4,700
0.0114%
$3.92$18,424+4.58%
2022-05-16PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
10,000
0.0235%
$3.38$33,800+8.86%
2021-12-02SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
1,500
0.001%
$4.10$6,150-18.11%
2021-03-15SaleAmneal Pharmaceuticals, Inc.
AMRX
SVP, Specialty Commercial
36,330
0.0097%
$2.75$99,908-26.36%
2020-02-28PurchaseAmneal Pharmaceuticals, Inc.
AMRX
SVP, Specialty Commercial
40,000
0.0256%
$3.62$144,800+13.25%
2019-05-13PurchaseAmneal Pharmaceuticals, Inc.
AMRX
SVP, Specialty Commercial
15,000
0.013%
$9.88$148,200-60.38%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.